WAVE Life Sciences to Present at the Jefferies 2016 Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)– WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company
focused on developing stereopure nucleic acid therapies for patients
with rare diseases, today announced that Paul Bolno, M.D., MBA,
President and Chief Executive Officer, will present at the Jefferies
2016 Healthcare Conference at 3:00 PM Eastern Time on Wednesday, June 8,
2016 in New York, NY.

A live webcast will also be available on the investor relations page of
WAVE Life Sciences’ (the Company) corporate website at http://ir.wavelifesciences.com./phoenix.zhtml?c=254233&p=irol-calendar.
After the live webcast, the event will remain archived on the Company’s
website until September 8, 2016.

About WAVE Life Sciences

At WAVE Life Sciences, we are driven by an unwavering passion and
commitment to deliver on our mission of confronting challenging diseases
by developing transformational therapies and empowering patients. We are
utilizing our innovative and proprietary synthetic chemistry drug
development platform to design, develop and commercialize stereopure
nucleic acid therapeutics that precisely target the underlying cause of
rare and other serious genetically defined diseases. Given the
versatility of our chemistry platform, WAVE’s deep, diverse pipeline
spans multiple modalities including antisense, exon-skipping, and
single-stranded RNAi. For more information, please visit www.wavelifesciences.com and
follow us on Twitter at @WAVELifeSci
and LinkedIn.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160601005129/en/